Danfei Chen
Impact in
-
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Lipid Membrane Structure and Behavior 1
- Co-authors
- Hongxia Tang (2 shared papers)Qianqian Song (2 shared papers)Weidong Fei (4 shared papers)Chaoqun Li (1 shared paper)Caihong Zheng (1 shared paper)Yue Zhang (1 shared paper)Xiaodong Wu (1 shared paper)Shunping Han (3 shared papers)
- Journals
- Theranostics (2 papers)Frontiers in Pharmacology (2 papers)Journal of drug targeting (1 paper)AAPS PharmSciTech (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaCzechiaUnited Kingdom
In The Last Decade
Danfei Chen
10 papers receiving 379 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 102
- Biomaterials 84
- Nephrology 42
- Pulmonary and Respiratory Medicine 144
- Biomedical Engineering 125
Countries citing papers authored by Danfei Chen
This map shows the geographic impact of Danfei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfei Chen more than expected).
Fields of papers citing papers by Danfei Chen
This network shows the impact of papers produced by Danfei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfei Chen. The network helps show where Danfei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Danfei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 147 | |
| 2 | 2020 | 88 | |
| 3 | 2019 | 69 | |
| 4 | 2018 | 47 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 9 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 2 | |
| 9 | 2025 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Danfei Chen
Danfei Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Nephrology, Biomaterials and Pharmaceutical Science, having authored 13 papers that have together received 380 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (2 papers), Advanced Drug Delivery Systems (2 papers), Chronic Kidney Disease and Diabetes (2 papers), MicroRNA in disease regulation (1 paper), Allergic Rhinitis and Sensitization (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Lipid Membrane Structure and Behavior (1 paper). The work is most often cited by research in Cancer Research (102 citations), Biomaterials (84 citations), Nephrology (42 citations), Pulmonary and Respiratory Medicine (144 citations) and Biomedical Engineering (125 citations). Danfei Chen has collaborated with scholars based in China, Czechia and United Kingdom. Frequent co-authors include Hongxia Tang, Qianqian Song, Weidong Fei, Chaoqun Li, Caihong Zheng, Yue Zhang, Xiaodong Wu, Shunping Han, Qunying Li and Yulian Wu. Their work appears in journals such as Theranostics, Frontiers in Pharmacology, Journal of drug targeting, AAPS PharmSciTech and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.